

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.86968030 |
| 2 | viral transcription (GO:0019083) | 4.62946048 |
| 3 | translational termination (GO:0006415) | 4.51588477 |
| 4 | pinocytosis (GO:0006907) | 4.34130410 |
| 5 | DNA deamination (GO:0045006) | 4.29798939 |
| 6 | response to interferon-beta (GO:0035456) | 4.16937920 |
| 7 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.16122260 |
| 8 | cotranslational protein targeting to membrane (GO:0006613) | 4.10630103 |
| 9 | protein targeting to ER (GO:0045047) | 4.04955339 |
| 10 | translational elongation (GO:0006414) | 3.99199869 |
| 11 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.94408511 |
| 12 | cellular response to interferon-beta (GO:0035458) | 3.92724546 |
| 13 | protein localization to endoplasmic reticulum (GO:0070972) | 3.86593648 |
| 14 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.82591189 |
| 15 | proteasome assembly (GO:0043248) | 3.81612913 |
| 16 | regulation of cholesterol esterification (GO:0010872) | 3.81244438 |
| 17 | regulation of superoxide anion generation (GO:0032928) | 3.78188300 |
| 18 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.76251201 |
| 19 | DNA strand elongation (GO:0022616) | 3.74698202 |
| 20 | ribosomal small subunit biogenesis (GO:0042274) | 3.72992237 |
| 21 | maturation of SSU-rRNA (GO:0030490) | 3.67230710 |
| 22 | plasma lipoprotein particle assembly (GO:0034377) | 3.65897985 |
| 23 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.53615090 |
| 24 | viral life cycle (GO:0019058) | 3.51770664 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.51392253 |
| 26 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.50486290 |
| 27 | cellular protein complex disassembly (GO:0043624) | 3.47625814 |
| 28 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.44845932 |
| 29 | platelet dense granule organization (GO:0060155) | 3.44618865 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.43363754 |
| 31 | NADPH regeneration (GO:0006740) | 3.42591229 |
| 32 | pentose-phosphate shunt (GO:0006098) | 3.41876636 |
| 33 | negative regulation of fibrinolysis (GO:0051918) | 3.40662243 |
| 34 | blood coagulation, intrinsic pathway (GO:0007597) | 3.38025140 |
| 35 | translational initiation (GO:0006413) | 3.36777651 |
| 36 | DNA unwinding involved in DNA replication (GO:0006268) | 3.35260635 |
| 37 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.33947295 |
| 38 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.32586701 |
| 39 | L-phenylalanine metabolic process (GO:0006558) | 3.32586701 |
| 40 | telomere maintenance via recombination (GO:0000722) | 3.31195817 |
| 41 | low-density lipoprotein particle remodeling (GO:0034374) | 3.29426756 |
| 42 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.25673110 |
| 43 | ribosomal large subunit biogenesis (GO:0042273) | 3.24819090 |
| 44 | cellular hyperosmotic response (GO:0071474) | 3.17046322 |
| 45 | protein-lipid complex assembly (GO:0065005) | 3.17005313 |
| 46 | positive regulation of B cell differentiation (GO:0045579) | 3.14998817 |
| 47 | establishment of integrated proviral latency (GO:0075713) | 3.10853046 |
| 48 | regulation of protein activation cascade (GO:2000257) | 3.09355163 |
| 49 | regulation of complement activation (GO:0030449) | 3.08547263 |
| 50 | translation (GO:0006412) | 3.07920197 |
| 51 | lymphoid progenitor cell differentiation (GO:0002320) | 3.07518439 |
| 52 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.03604428 |
| 53 | protein complex disassembly (GO:0043241) | 3.03119904 |
| 54 | regulation of apoptotic cell clearance (GO:2000425) | 3.01260699 |
| 55 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.01079650 |
| 56 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.97962018 |
| 57 | negative regulation of ligase activity (GO:0051352) | 2.97789537 |
| 58 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.97789537 |
| 59 | DNA replication initiation (GO:0006270) | 2.97428849 |
| 60 | formation of translation preinitiation complex (GO:0001731) | 2.96243998 |
| 61 | mitotic recombination (GO:0006312) | 2.96093514 |
| 62 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.95387229 |
| 63 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.95387229 |
| 64 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.94792253 |
| 65 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.94218638 |
| 66 | neutrophil activation involved in immune response (GO:0002283) | 2.93394901 |
| 67 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.93255015 |
| 68 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.93255015 |
| 69 | modulation by symbiont of host immune response (GO:0052553) | 2.93255015 |
| 70 | positive regulation by symbiont of host defense response (GO:0052509) | 2.93255015 |
| 71 | modulation by symbiont of host defense response (GO:0052031) | 2.93255015 |
| 72 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.93255015 |
| 73 | endosome to melanosome transport (GO:0035646) | 2.91984261 |
| 74 | endosome to pigment granule transport (GO:0043485) | 2.91984261 |
| 75 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.89675120 |
| 76 | protein carboxylation (GO:0018214) | 2.89675120 |
| 77 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.89591335 |
| 78 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.89591335 |
| 79 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.89591335 |
| 80 | L-phenylalanine catabolic process (GO:0006559) | 2.89433973 |
| 81 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.89433973 |
| 82 | peptide catabolic process (GO:0043171) | 2.88412663 |
| 83 | regulation of fibrinolysis (GO:0051917) | 2.87613450 |
| 84 | macromolecular complex disassembly (GO:0032984) | 2.86055717 |
| 85 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.85774064 |
| 86 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.85439492 |
| 87 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.84776542 |
| 88 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.84776542 |
| 89 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.83178953 |
| 90 | establishment of viral latency (GO:0019043) | 2.81825865 |
| 91 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.80917466 |
| 92 | regulation of mitochondrial translation (GO:0070129) | 2.80632103 |
| 93 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.80420953 |
| 94 | termination of RNA polymerase III transcription (GO:0006386) | 2.80420953 |
| 95 | pseudouridine synthesis (GO:0001522) | 2.77729316 |
| 96 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.76125457 |
| 97 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.76125457 |
| 98 | negative regulation of humoral immune response (GO:0002921) | 2.75575355 |
| 99 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.75418636 |
| 100 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.74190008 |
| 101 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.73763611 |
| 102 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.72104858 |
| 103 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.72104858 |
| 104 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.72095701 |
| 105 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.72095701 |
| 106 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.71429689 |
| 107 | detection of other organism (GO:0098543) | 2.71194334 |
| 108 | negative regulation of protein activation cascade (GO:2000258) | 2.70987106 |
| 109 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.70650349 |
| 110 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.69736098 |
| 111 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.69618832 |
| 112 | immunoglobulin mediated immune response (GO:0016064) | 2.68944148 |
| 113 | telomere maintenance via telomere lengthening (GO:0010833) | 2.67361804 |
| 114 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.66789363 |
| 115 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.66285728 |
| 116 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.65673253 |
| 117 | COPI coating of Golgi vesicle (GO:0048205) | 2.65464441 |
| 118 | Golgi transport vesicle coating (GO:0048200) | 2.65464441 |
| 119 | mast cell activation (GO:0045576) | 2.64614365 |
| 120 | cholesterol efflux (GO:0033344) | 2.62228430 |
| 121 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.62192059 |
| 122 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.62192059 |
| 123 | NADH dehydrogenase complex assembly (GO:0010257) | 2.62192059 |
| 124 | L-ascorbic acid metabolic process (GO:0019852) | 2.61084875 |
| 125 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.60113503 |
| 126 | mRNA catabolic process (GO:0006402) | 2.59149942 |
| 127 | protein targeting to membrane (GO:0006612) | 2.59044515 |
| 128 | defense response to protozoan (GO:0042832) | 2.58817405 |
| 129 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.57391440 |
| 130 | detection of bacterium (GO:0016045) | 2.56635639 |
| 131 | detection of molecule of bacterial origin (GO:0032490) | 2.55071305 |
| 132 | detection of external biotic stimulus (GO:0098581) | 2.54727967 |
| 133 | negative regulation of complement activation (GO:0045916) | 2.54723445 |
| 134 | NADH metabolic process (GO:0006734) | 2.54079351 |
| 135 | proline biosynthetic process (GO:0006561) | 2.53431930 |
| 136 | glucose catabolic process (GO:0006007) | 2.52871134 |
| 137 | response to peptidoglycan (GO:0032494) | 2.51858218 |
| 138 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.51479052 |
| 139 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.51479052 |
| 140 | plasma lipoprotein particle organization (GO:0071827) | 2.48823737 |
| 141 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.48332566 |
| 142 | protein maturation by protein folding (GO:0022417) | 2.48177262 |
| 143 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.47529055 |
| 144 | RNA catabolic process (GO:0006401) | 2.46975120 |
| 145 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.46865656 |
| 146 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.46865656 |
| 147 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.46437107 |
| 148 | regulation of B cell differentiation (GO:0045577) | 2.46021088 |
| 149 | regulation of superoxide metabolic process (GO:0090322) | 2.45833529 |
| 150 | * purine-containing compound salvage (GO:0043101) | 2.45832739 |
| 151 | nucleobase biosynthetic process (GO:0046112) | 2.45358821 |
| 152 | rRNA processing (GO:0006364) | 2.45278937 |
| 153 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.45185537 |
| 154 | histone mRNA metabolic process (GO:0008334) | 2.43227332 |
| 155 | IMP biosynthetic process (GO:0006188) | 2.43133183 |
| 156 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.43061758 |
| 157 | response to host immune response (GO:0052572) | 2.43061758 |
| 158 | alpha-linolenic acid metabolic process (GO:0036109) | 2.43034782 |
| 159 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.42885481 |
| 160 | response to host defenses (GO:0052200) | 2.42282739 |
| 161 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.42282739 |
| 162 | response to host (GO:0075136) | 2.42282739 |
| 163 | negative regulation of cell killing (GO:0031342) | 2.41369075 |
| 164 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.41369075 |
| 165 | B cell mediated immunity (GO:0019724) | 2.40615254 |
| 166 | regulation of translation in response to stress (GO:0043555) | 2.38962495 |
| 167 | response to protozoan (GO:0001562) | 2.38771408 |
| 168 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.38647646 |
| 169 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.37855087 |
| 170 | protein-lipid complex remodeling (GO:0034368) | 2.37498577 |
| 171 | macromolecular complex remodeling (GO:0034367) | 2.37498577 |
| 172 | plasma lipoprotein particle remodeling (GO:0034369) | 2.37498577 |
| 173 | pentose metabolic process (GO:0019321) | 2.34038259 |
| 174 | ribosome assembly (GO:0042255) | 2.31630867 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.55769440 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.86598023 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.70165224 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.50525008 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.41681421 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.33082198 |
| 7 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.26341114 |
| 8 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.12671293 |
| 9 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.12074977 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.92073303 |
| 11 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.90214149 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.82296110 |
| 13 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.77453483 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.77278544 |
| 15 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.72353436 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.65973812 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.65280056 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.64497513 |
| 19 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.61794892 |
| 20 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.43549004 |
| 21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42780522 |
| 22 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.35768030 |
| 23 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.31313738 |
| 24 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29911496 |
| 25 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.27271707 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.24698034 |
| 27 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.23338151 |
| 28 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.22322951 |
| 29 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.18549363 |
| 30 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.17712072 |
| 31 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.14051013 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.09215319 |
| 33 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.08288563 |
| 34 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.06290870 |
| 35 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.04150414 |
| 36 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.02460027 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02305010 |
| 38 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.96735990 |
| 39 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.92783479 |
| 40 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.92204407 |
| 41 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.91132106 |
| 42 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.89267588 |
| 43 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.86857310 |
| 44 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80060019 |
| 45 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.78084742 |
| 46 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.77397974 |
| 47 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.77266616 |
| 48 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68928717 |
| 49 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.68757997 |
| 50 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.63483340 |
| 51 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.63056440 |
| 52 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.60789850 |
| 53 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.57949335 |
| 54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.56802838 |
| 55 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.56138826 |
| 56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56114015 |
| 57 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.53477053 |
| 58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.51724000 |
| 59 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.51037582 |
| 60 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.50694666 |
| 61 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.48591984 |
| 62 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.47301747 |
| 63 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.46132722 |
| 64 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.42829660 |
| 65 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41660696 |
| 66 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.39782236 |
| 67 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.38477846 |
| 68 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.37845762 |
| 69 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37455405 |
| 70 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.36666730 |
| 71 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.34017175 |
| 72 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.33360787 |
| 73 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32340096 |
| 74 | MYC_22102868_ChIP-Seq_BL_Human | 1.31258009 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31059954 |
| 76 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.28636882 |
| 77 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.27075972 |
| 78 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26149581 |
| 79 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24479167 |
| 80 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.24072519 |
| 81 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.23945807 |
| 82 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.21893217 |
| 83 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17589516 |
| 84 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17527514 |
| 85 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.17372644 |
| 86 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17127690 |
| 87 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17014463 |
| 88 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16984719 |
| 89 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.16466053 |
| 90 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.15849786 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15805614 |
| 92 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.15704149 |
| 93 | * MYB_26560356_Chip-Seq_TH2_Human | 1.14129455 |
| 94 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13453518 |
| 95 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.11806599 |
| 96 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.11756621 |
| 97 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09915155 |
| 98 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.08665975 |
| 99 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.07933065 |
| 100 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06839625 |
| 101 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.06671752 |
| 102 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.06191446 |
| 103 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.05975440 |
| 104 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.05085051 |
| 105 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.03296387 |
| 106 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.02070635 |
| 107 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.01960569 |
| 108 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01890414 |
| 109 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01823654 |
| 110 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.01523362 |
| 111 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.00904321 |
| 112 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00554013 |
| 113 | SPI1_23127762_ChIP-Seq_K562_Human | 1.00547706 |
| 114 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98962439 |
| 115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98092075 |
| 116 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97918507 |
| 117 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96986116 |
| 118 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.96854808 |
| 119 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96410154 |
| 120 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.96333559 |
| 121 | MYB_26560356_Chip-Seq_TH1_Human | 0.95787607 |
| 122 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.93855768 |
| 123 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93778079 |
| 124 | MAF_26560356_Chip-Seq_TH1_Human | 0.92891346 |
| 125 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87724416 |
| 126 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 0.86993047 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.91395284 |
| 2 | MP0005360_urolithiasis | 3.44313397 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.21918735 |
| 4 | MP0005671_abnormal_response_to | 3.17536518 |
| 5 | MP0008260_abnormal_autophagy | 3.14188208 |
| 6 | MP0009785_altered_susceptibility_to | 3.10474914 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.87418531 |
| 8 | MP0000685_abnormal_immune_system | 2.86917179 |
| 9 | MP0003693_abnormal_embryo_hatching | 2.61520782 |
| 10 | MP0005025_abnormal_response_to | 2.58792109 |
| 11 | MP0003724_increased_susceptibility_to | 2.46793634 |
| 12 | MP0002419_abnormal_innate_immunity | 2.41896295 |
| 13 | MP0008058_abnormal_DNA_repair | 2.37535588 |
| 14 | MP0001853_heart_inflammation | 2.36813752 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 2.36447112 |
| 16 | MP0010094_abnormal_chromosome_stability | 2.36198251 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.34040388 |
| 18 | MP0003122_maternal_imprinting | 2.32954331 |
| 19 | MP0004147_increased_porphyrin_level | 2.32868623 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.25313628 |
| 21 | MP0001800_abnormal_humoral_immune | 2.22731154 |
| 22 | MP0002723_abnormal_immune_serum | 2.16890869 |
| 23 | MP0005365_abnormal_bile_salt | 2.11822348 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 2.11624517 |
| 25 | MP0005058_abnormal_lysosome_morphology | 2.11472787 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.11348579 |
| 27 | MP0002398_abnormal_bone_marrow | 2.10508187 |
| 28 | MP0001819_abnormal_immune_cell | 2.09922996 |
| 29 | MP0003436_decreased_susceptibility_to | 2.08099406 |
| 30 | MP0008007_abnormal_cellular_replicative | 2.04144422 |
| 31 | MP0003077_abnormal_cell_cycle | 2.03690177 |
| 32 | MP0005464_abnormal_platelet_physiology | 2.01082930 |
| 33 | MP0003763_abnormal_thymus_physiology | 2.00456865 |
| 34 | MP0000490_abnormal_crypts_of | 1.97873933 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.95747517 |
| 36 | MP0005408_hypopigmentation | 1.94341163 |
| 37 | MP0005174_abnormal_tail_pigmentation | 1.94339977 |
| 38 | MP0000716_abnormal_immune_system | 1.91494046 |
| 39 | MP0008057_abnormal_DNA_replication | 1.90950596 |
| 40 | MP0002405_respiratory_system_inflammati | 1.87738393 |
| 41 | MP0005387_immune_system_phenotype | 1.87005830 |
| 42 | MP0001790_abnormal_immune_system | 1.87005830 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.83958159 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.82797049 |
| 45 | MP0003186_abnormal_redox_activity | 1.82131161 |
| 46 | MP0002722_abnormal_immune_system | 1.80989272 |
| 47 | MP0002429_abnormal_blood_cell | 1.79312606 |
| 48 | MP0004957_abnormal_blastocyst_morpholog | 1.78480757 |
| 49 | MP0009379_abnormal_foot_pigmentation | 1.77513148 |
| 50 | MP0006082_CNS_inflammation | 1.77276894 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.75417156 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.69217605 |
| 53 | MP0006054_spinal_hemorrhage | 1.65959950 |
| 54 | MP0005075_abnormal_melanosome_morpholog | 1.58786219 |
| 55 | MP0005085_abnormal_gallbladder_physiolo | 1.53698997 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.41696413 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.41696413 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.41164737 |
| 59 | MP0003111_abnormal_nucleus_morphology | 1.40035534 |
| 60 | MP0000015_abnormal_ear_pigmentation | 1.39975387 |
| 61 | MP0008875_abnormal_xenobiotic_pharmacok | 1.39760209 |
| 62 | MP0001873_stomach_inflammation | 1.39444933 |
| 63 | MP0010155_abnormal_intestine_physiology | 1.36088079 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.34201596 |
| 65 | MP0008469_abnormal_protein_level | 1.33338644 |
| 66 | MP0000604_amyloidosis | 1.32761963 |
| 67 | MP0000703_abnormal_thymus_morphology | 1.32493092 |
| 68 | MP0000343_altered_response_to | 1.28886306 |
| 69 | MP0002095_abnormal_skin_pigmentation | 1.26334594 |
| 70 | MP0000609_abnormal_liver_physiology | 1.25209456 |
| 71 | MP0001529_abnormal_vocalization | 1.23735293 |
| 72 | MP0003123_paternal_imprinting | 1.22540163 |
| 73 | MP0002132_abnormal_respiratory_system | 1.21876851 |
| 74 | MP0002166_altered_tumor_susceptibility | 1.21316144 |
| 75 | MP0010329_abnormal_lipoprotein_level | 1.21267733 |
| 76 | MP0001533_abnormal_skeleton_physiology | 1.21183682 |
| 77 | MP0005451_abnormal_body_composition | 1.18695030 |
| 78 | MP0003866_abnormal_defecation | 1.18559372 |
| 79 | MP0008932_abnormal_embryonic_tissue | 1.17425350 |
| 80 | MP0003075_altered_response_to | 1.17259851 |
| 81 | MP0009697_abnormal_copulation | 1.16820935 |
| 82 | MP0003941_abnormal_skin_development | 1.15912550 |
| 83 | MP0004264_abnormal_extraembryonic_tissu | 1.11202268 |
| 84 | MP0003195_calcinosis | 1.09643642 |
| 85 | MP0005319_abnormal_enzyme/_coenzyme | 1.08415262 |
| 86 | MP0003300_gastrointestinal_ulcer | 1.07199981 |
| 87 | MP0000566_synostosis | 1.07169579 |
| 88 | MP0002019_abnormal_tumor_incidence | 1.03645779 |
| 89 | MP0003943_abnormal_hepatobiliary_system | 1.03064759 |
| 90 | MP0002933_joint_inflammation | 1.02250642 |
| 91 | MP0000598_abnormal_liver_morphology | 1.02105339 |
| 92 | MP0000313_abnormal_cell_death | 1.01959983 |
| 93 | MP0001915_intracranial_hemorrhage | 1.00480941 |
| 94 | MP0009764_decreased_sensitivity_to | 0.94971858 |
| 95 | MP0000858_altered_metastatic_potential | 0.94755905 |
| 96 | MP0001730_embryonic_growth_arrest | 0.90722723 |
| 97 | MP0009840_abnormal_foam_cell | 0.89878556 |
| 98 | MP0003448_altered_tumor_morphology | 0.89262971 |
| 99 | MP0004019_abnormal_vitamin_homeostasis | 0.89148881 |
| 100 | MP0000358_abnormal_cell_content/ | 0.88917714 |
| 101 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.87749014 |
| 102 | MP0002006_tumorigenesis | 0.87669145 |
| 103 | MP0001764_abnormal_homeostasis | 0.85771705 |
| 104 | MP0000678_abnormal_parathyroid_gland | 0.85654772 |
| 105 | MP0001663_abnormal_digestive_system | 0.85050464 |
| 106 | MP0005409_darkened_coat_color | 0.84463305 |
| 107 | MP0002277_abnormal_respiratory_mucosa | 0.82980006 |
| 108 | MP0006036_abnormal_mitochondrial_physio | 0.82369470 |
| 109 | MP0003806_abnormal_nucleotide_metabolis | 0.81589073 |
| 110 | MP0005164_abnormal_response_to | 0.78572758 |
| 111 | MP0005332_abnormal_amino_acid | 0.77887145 |
| 112 | MP0001293_anophthalmia | 0.77868602 |
| 113 | MP0003828_pulmonary_edema | 0.76940332 |
| 114 | MP0004883_abnormal_blood_vessel | 0.76407814 |
| 115 | MP0003252_abnormal_bile_duct | 0.75673795 |
| 116 | MP0000350_abnormal_cell_proliferation | 0.75539080 |
| 117 | MP0001849_ear_inflammation | 0.75282788 |
| 118 | MP0008873_increased_physiological_sensi | 0.75178951 |
| 119 | MP0009763_increased_sensitivity_to | 0.74866876 |
| 120 | MP0010307_abnormal_tumor_latency | 0.74159464 |
| 121 | MP0002938_white_spotting | 0.73501925 |
| 122 | MP0000249_abnormal_blood_vessel | 0.68433756 |
| 123 | MP0003303_peritoneal_inflammation | 0.68293296 |
| 124 | MP0006035_abnormal_mitochondrial_morpho | 0.67612098 |
| 125 | MP0003183_abnormal_peptide_metabolism | 0.66737467 |
| 126 | MP0004947_skin_inflammation | 0.65693357 |
| 127 | MP0005376_homeostasis/metabolism_phenot | 0.65024613 |
| 128 | MP0005310_abnormal_salivary_gland | 0.63678602 |
| 129 | MP0003191_abnormal_cellular_cholesterol | 0.63342462 |
| 130 | MP0001727_abnormal_embryo_implantation | 0.62501143 |
| 131 | MP0001905_abnormal_dopamine_level | 0.62496600 |
| 132 | MP0010368_abnormal_lymphatic_system | 0.61412231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.51725032 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.50996262 |
| 3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.86204360 |
| 4 | Abnormal number of erythroid precursors (HP:0012131) | 4.78143171 |
| 5 | Petechiae (HP:0000967) | 4.23157053 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 3.78907595 |
| 7 | Thrombocytosis (HP:0001894) | 3.76647374 |
| 8 | Joint hemorrhage (HP:0005261) | 3.74170237 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.71676027 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 3.63024536 |
| 11 | Myositis (HP:0100614) | 3.57055284 |
| 12 | Reticulocytopenia (HP:0001896) | 3.54073343 |
| 13 | Aplastic anemia (HP:0001915) | 3.53533109 |
| 14 | IgM deficiency (HP:0002850) | 3.47201550 |
| 15 | Type I transferrin isoform profile (HP:0003642) | 3.27621056 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.26588382 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 3.19262984 |
| 18 | Menorrhagia (HP:0000132) | 3.19190887 |
| 19 | Recurrent bacterial skin infections (HP:0005406) | 3.17559775 |
| 20 | Hypobetalipoproteinemia (HP:0003563) | 3.16041888 |
| 21 | Chronic otitis media (HP:0000389) | 3.05588750 |
| 22 | Poor head control (HP:0002421) | 3.01570755 |
| 23 | Reduced antithrombin III activity (HP:0001976) | 3.00745555 |
| 24 | Gingival bleeding (HP:0000225) | 2.99687558 |
| 25 | Glomerulonephritis (HP:0000099) | 2.91545241 |
| 26 | Exertional dyspnea (HP:0002875) | 2.90915051 |
| 27 | Pallor (HP:0000980) | 2.87797461 |
| 28 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.83881540 |
| 29 | Macrocytic anemia (HP:0001972) | 2.81987021 |
| 30 | 3-Methylglutaconic aciduria (HP:0003535) | 2.78118329 |
| 31 | Hepatocellular necrosis (HP:0001404) | 2.77466372 |
| 32 | Abnormal protein glycosylation (HP:0012346) | 2.66244446 |
| 33 | Abnormal glycosylation (HP:0012345) | 2.66244446 |
| 34 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.66244446 |
| 35 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.66244446 |
| 36 | Viral hepatitis (HP:0006562) | 2.62995165 |
| 37 | Mitochondrial inheritance (HP:0001427) | 2.61157247 |
| 38 | Agnosia (HP:0010524) | 2.57278729 |
| 39 | Complement deficiency (HP:0004431) | 2.54987539 |
| 40 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.54239387 |
| 41 | Hepatic necrosis (HP:0002605) | 2.51048023 |
| 42 | Abnormality of macrophages (HP:0004311) | 2.48259095 |
| 43 | Eczematoid dermatitis (HP:0000976) | 2.46546555 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.45063701 |
| 45 | Gastrointestinal infarctions (HP:0005244) | 2.44255216 |
| 46 | Oral leukoplakia (HP:0002745) | 2.43406383 |
| 47 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.42397607 |
| 48 | Increased hepatocellular lipid droplets (HP:0006565) | 2.42306603 |
| 49 | Epistaxis (HP:0000421) | 2.40167667 |
| 50 | Orchitis (HP:0100796) | 2.40063557 |
| 51 | Purpura (HP:0000979) | 2.39841876 |
| 52 | Recurrent viral infections (HP:0004429) | 2.39128276 |
| 53 | Hepatosplenomegaly (HP:0001433) | 2.38892302 |
| 54 | Hypercholesterolemia (HP:0003124) | 2.38604647 |
| 55 | Mediastinal lymphadenopathy (HP:0100721) | 2.37938294 |
| 56 | Amyloidosis (HP:0011034) | 2.37849992 |
| 57 | Hemorrhage of the eye (HP:0011885) | 2.37753039 |
| 58 | Increased CSF lactate (HP:0002490) | 2.36285285 |
| 59 | Acute necrotizing encephalopathy (HP:0006965) | 2.35345448 |
| 60 | Hepatocellular carcinoma (HP:0001402) | 2.30363232 |
| 61 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.30314469 |
| 62 | Abnormality of complement system (HP:0005339) | 2.27284114 |
| 63 | Increased serum pyruvate (HP:0003542) | 2.26477340 |
| 64 | Abnormality of glycolysis (HP:0004366) | 2.26477340 |
| 65 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.26399124 |
| 66 | Renal Fanconi syndrome (HP:0001994) | 2.25438339 |
| 67 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.24353263 |
| 68 | Pancytopenia (HP:0001876) | 2.23555053 |
| 69 | Increased serum lactate (HP:0002151) | 2.23048710 |
| 70 | Panhypogammaglobulinemia (HP:0003139) | 2.22451781 |
| 71 | Abnormality of the peritoneum (HP:0002585) | 2.20713594 |
| 72 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.18490163 |
| 73 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.18490163 |
| 74 | B lymphocytopenia (HP:0010976) | 2.18335760 |
| 75 | Abnormality of B cell number (HP:0010975) | 2.18335760 |
| 76 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.18085301 |
| 77 | Lipid accumulation in hepatocytes (HP:0006561) | 2.17728417 |
| 78 | Interstitial pulmonary disease (HP:0006530) | 2.17547013 |
| 79 | Lymphoma (HP:0002665) | 2.16984497 |
| 80 | IgG deficiency (HP:0004315) | 2.16259404 |
| 81 | Subacute progressive viral hepatitis (HP:0006572) | 2.16193422 |
| 82 | Obstructive lung disease (HP:0006536) | 2.16092519 |
| 83 | Chronic obstructive pulmonary disease (HP:0006510) | 2.16092519 |
| 84 | Increased serum ferritin (HP:0003281) | 2.14905254 |
| 85 | Cerebral hypomyelination (HP:0006808) | 2.13890669 |
| 86 | Myocardial infarction (HP:0001658) | 2.13309808 |
| 87 | Abnormal gallbladder physiology (HP:0012438) | 2.13000518 |
| 88 | Cholecystitis (HP:0001082) | 2.13000518 |
| 89 | Basal ganglia calcification (HP:0002135) | 2.10612436 |
| 90 | Recurrent bronchitis (HP:0002837) | 2.09213816 |
| 91 | Retrobulbar optic neuritis (HP:0100654) | 2.09175086 |
| 92 | Optic neuritis (HP:0100653) | 2.09175086 |
| 93 | Recurrent skin infections (HP:0001581) | 2.07735855 |
| 94 | Hypoplasia of the thymus (HP:0000778) | 2.07480294 |
| 95 | Xanthomatosis (HP:0000991) | 2.06263352 |
| 96 | Hyperammonemia (HP:0001987) | 2.06077455 |
| 97 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.04980207 |
| 98 | Spastic diplegia (HP:0001264) | 2.04741903 |
| 99 | Hyperglycinemia (HP:0002154) | 2.03621207 |
| 100 | Abnormality of methionine metabolism (HP:0010901) | 2.00960301 |
| 101 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.99537932 |
| 102 | Abnormality of the prostate (HP:0008775) | 1.98998430 |
| 103 | Thyroiditis (HP:0100646) | 1.98418294 |
| 104 | Increased IgM level (HP:0003496) | 1.98213017 |
| 105 | Premature graying of hair (HP:0002216) | 1.98209582 |
| 106 | Urticaria (HP:0001025) | 1.97773176 |
| 107 | Abnormality of iron homeostasis (HP:0011031) | 1.97214496 |
| 108 | Episodic fever (HP:0001954) | 1.96370204 |
| 109 | Acute hepatic failure (HP:0006554) | 1.94839990 |
| 110 | Type 2 muscle fiber atrophy (HP:0003554) | 1.94211338 |
| 111 | Vertebral compression fractures (HP:0002953) | 1.93681441 |
| 112 | Meningitis (HP:0001287) | 1.93541056 |
| 113 | Multiple enchondromatosis (HP:0005701) | 1.91685553 |
| 114 | Vasculitis (HP:0002633) | 1.91249618 |
| 115 | Abnormality of T cell physiology (HP:0011840) | 1.90911862 |
| 116 | Severe combined immunodeficiency (HP:0004430) | 1.90308494 |
| 117 | Increased cerebral lipofuscin (HP:0011813) | 1.90222732 |
| 118 | Neutropenia (HP:0001875) | 1.90083786 |
| 119 | Small epiphyses (HP:0010585) | 1.89906038 |
| 120 | Increased intramyocellular lipid droplets (HP:0012240) | 1.89722075 |
| 121 | Acute encephalopathy (HP:0006846) | 1.89502610 |
| 122 | Cellulitis (HP:0100658) | 1.89448185 |
| 123 | Lymphopenia (HP:0001888) | 1.87696602 |
| 124 | Acanthocytosis (HP:0001927) | 1.86741508 |
| 125 | Leukopenia (HP:0001882) | 1.86382145 |
| 126 | Irregular epiphyses (HP:0010582) | 1.86157840 |
| 127 | Prolonged bleeding time (HP:0003010) | 1.85910553 |
| 128 | Respiratory difficulties (HP:0002880) | 1.85268694 |
| 129 | Severe visual impairment (HP:0001141) | 1.85154420 |
| 130 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.84603227 |
| 131 | CNS hypomyelination (HP:0003429) | 1.84000950 |
| 132 | Amaurosis fugax (HP:0100576) | 1.83355909 |
| 133 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.83231880 |
| 134 | Recurrent fungal infections (HP:0002841) | 1.80509820 |
| 135 | Rough bone trabeculation (HP:0100670) | 1.79473199 |
| 136 | Leukocytosis (HP:0001974) | 1.79099310 |
| 137 | Muscle fiber atrophy (HP:0100295) | 1.78805369 |
| 138 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.78786491 |
| 139 | Dysostosis multiplex (HP:0000943) | 1.78511383 |
| 140 | Microvesicular hepatic steatosis (HP:0001414) | 1.78189923 |
| 141 | Lactic acidosis (HP:0003128) | 1.77852037 |
| 142 | Gastrointestinal stroma tumor (HP:0100723) | 1.77624663 |
| 143 | 11 pairs of ribs (HP:0000878) | 1.77585627 |
| 144 | Abnormality of T cells (HP:0002843) | 1.77074049 |
| 145 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.76495995 |
| 146 | Neoplasm of the liver (HP:0002896) | 1.75152781 |
| 147 | Polygenic inheritance (HP:0010982) | 1.75120633 |
| 148 | Spastic paraparesis (HP:0002313) | 1.74772811 |
| 149 | Colitis (HP:0002583) | 1.74685595 |
| 150 | Encephalitis (HP:0002383) | 1.74597985 |
| 151 | Beaking of vertebral bodies (HP:0004568) | 1.74444338 |
| 152 | Mucopolysacchariduria (HP:0008155) | 1.73999948 |
| 153 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.73999948 |
| 154 | Micronodular cirrhosis (HP:0001413) | 1.73924132 |
| 155 | Gastrointestinal inflammation (HP:0004386) | 1.73490844 |
| 156 | Thrombophlebitis (HP:0004418) | 1.72986366 |
| 157 | Gingivitis (HP:0000230) | 1.72518169 |
| 158 | Anorexia (HP:0002039) | 1.71153137 |
| 159 | Abnormal platelet volume (HP:0011876) | 1.70173827 |
| 160 | Abnormality of carpal bone ossification (HP:0006257) | 1.69925825 |
| 161 | Embryonal renal neoplasm (HP:0011794) | 1.69732411 |
| 162 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.69623355 |
| 163 | Pustule (HP:0200039) | 1.68382233 |
| 164 | Hypolipoproteinemia (HP:0010981) | 1.67522480 |
| 165 | Papillary thyroid carcinoma (HP:0002895) | 1.67199327 |
| 166 | Ragged-red muscle fibers (HP:0003200) | 1.64600762 |
| 167 | Peritonitis (HP:0002586) | 1.62610989 |
| 168 | Epidermoid cyst (HP:0200040) | 1.61884471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 3.68055113 |
| 2 | VRK2 | 3.26344566 |
| 3 | SMG1 | 3.02258464 |
| 4 | BUB1 | 2.91891648 |
| 5 | MAP4K1 | 2.52078927 |
| 6 | WEE1 | 2.44974497 |
| 7 | KIT | 2.38424811 |
| 8 | NME2 | 2.30265417 |
| 9 | BLK | 2.24645984 |
| 10 | TGFBR1 | 2.24037458 |
| 11 | EIF2AK3 | 2.20365988 |
| 12 | FGFR4 | 2.12903953 |
| 13 | EIF2AK1 | 2.11687771 |
| 14 | ACVR1B | 1.95733628 |
| 15 | BTK | 1.95457703 |
| 16 | IRAK4 | 1.94234541 |
| 17 | TEC | 1.92986060 |
| 18 | MAP3K12 | 1.87556399 |
| 19 | VRK1 | 1.86810982 |
| 20 | CDK19 | 1.86806674 |
| 21 | TNIK | 1.85641903 |
| 22 | PIM2 | 1.83068854 |
| 23 | CSF1R | 1.82441223 |
| 24 | FGR | 1.70335847 |
| 25 | KDR | 1.70078266 |
| 26 | ZAP70 | 1.67857816 |
| 27 | TBK1 | 1.58620093 |
| 28 | TGFBR2 | 1.57128907 |
| 29 | CCNB1 | 1.54391959 |
| 30 | BMPR1B | 1.50579956 |
| 31 | SYK | 1.41462891 |
| 32 | TXK | 1.41405310 |
| 33 | TESK2 | 1.40927834 |
| 34 | NEK1 | 1.38432779 |
| 35 | ERN1 | 1.36926208 |
| 36 | DYRK3 | 1.36353111 |
| 37 | TSSK6 | 1.30889009 |
| 38 | EPHA2 | 1.29777864 |
| 39 | FLT3 | 1.29407974 |
| 40 | FGFR3 | 1.25645588 |
| 41 | PBK | 1.23473734 |
| 42 | CSK | 1.23139605 |
| 43 | TYK2 | 1.23102997 |
| 44 | SIK3 | 1.22838003 |
| 45 | CLK1 | 1.20674480 |
| 46 | MKNK1 | 1.19255725 |
| 47 | JAK3 | 1.18063804 |
| 48 | LYN | 1.14716187 |
| 49 | CDC7 | 1.13140089 |
| 50 | TAF1 | 1.12360739 |
| 51 | DYRK1B | 1.11362239 |
| 52 | IKBKB | 1.09277817 |
| 53 | MAP3K3 | 1.05008002 |
| 54 | PASK | 1.05001397 |
| 55 | MUSK | 1.04246951 |
| 56 | ADRBK2 | 1.04162408 |
| 57 | MST4 | 1.04009932 |
| 58 | PAK4 | 1.03283315 |
| 59 | YES1 | 1.02877274 |
| 60 | CDK6 | 1.02194671 |
| 61 | CDK8 | 0.99111439 |
| 62 | ATR | 0.97775786 |
| 63 | GRK7 | 0.97193334 |
| 64 | MATK | 0.94031676 |
| 65 | EIF2AK2 | 0.92140819 |
| 66 | STK10 | 0.91819608 |
| 67 | MYLK | 0.90703224 |
| 68 | LCK | 0.88743585 |
| 69 | NEK2 | 0.87341331 |
| 70 | TLK1 | 0.86262251 |
| 71 | BRSK2 | 0.84574123 |
| 72 | PDK2 | 0.84429752 |
| 73 | FES | 0.83844002 |
| 74 | CDK7 | 0.83462980 |
| 75 | FGFR1 | 0.82537309 |
| 76 | TTK | 0.82219284 |
| 77 | TESK1 | 0.81512610 |
| 78 | IKBKE | 0.80687903 |
| 79 | PLK3 | 0.80665479 |
| 80 | RPS6KB2 | 0.79671823 |
| 81 | ZAK | 0.78548210 |
| 82 | NEK9 | 0.78177644 |
| 83 | MAPKAPK3 | 0.77284828 |
| 84 | PKN2 | 0.75844150 |
| 85 | RPS6KA4 | 0.71371148 |
| 86 | MAP3K11 | 0.71163433 |
| 87 | ICK | 0.71056849 |
| 88 | TNK2 | 0.70815366 |
| 89 | TIE1 | 0.70709749 |
| 90 | BMX | 0.70626592 |
| 91 | ITK | 0.70334473 |
| 92 | MAPKAPK5 | 0.69111153 |
| 93 | PTK6 | 0.68585024 |
| 94 | ILK | 0.67783431 |
| 95 | AURKB | 0.66850761 |
| 96 | NUAK1 | 0.66495968 |
| 97 | CDK9 | 0.65964866 |
| 98 | RIPK4 | 0.65891767 |
| 99 | MAP3K5 | 0.65046330 |
| 100 | NLK | 0.61486276 |
| 101 | SCYL2 | 0.61042157 |
| 102 | MAP3K14 | 0.60529082 |
| 103 | EEF2K | 0.60381687 |
| 104 | HCK | 0.59370105 |
| 105 | PDPK1 | 0.58676802 |
| 106 | DAPK1 | 0.58627080 |
| 107 | MAP2K3 | 0.57729408 |
| 108 | GRK6 | 0.57453508 |
| 109 | SRPK1 | 0.57376720 |
| 110 | ALK | 0.57333169 |
| 111 | IRAK2 | 0.56561877 |
| 112 | BRSK1 | 0.56426550 |
| 113 | MAP3K7 | 0.55714638 |
| 114 | DYRK2 | 0.54453868 |
| 115 | CDK4 | 0.53945443 |
| 116 | MAP3K8 | 0.51415743 |
| 117 | LRRK2 | 0.51185963 |
| 118 | TAOK2 | 0.49726657 |
| 119 | MAP2K2 | 0.49700293 |
| 120 | MELK | 0.49253337 |
| 121 | PAK1 | 0.48991937 |
| 122 | PLK1 | 0.48590978 |
| 123 | CSNK2A1 | 0.48472063 |
| 124 | MAPKAPK2 | 0.48382965 |
| 125 | NME1 | 0.48360299 |
| 126 | IRAK3 | 0.47572238 |
| 127 | MAPK4 | 0.46742223 |
| 128 | AURKA | 0.46636892 |
| 129 | LIMK1 | 0.45719342 |
| 130 | JAK2 | 0.43211231 |
| 131 | TRPM7 | 0.41444925 |
| 132 | PRKD2 | 0.40759427 |
| 133 | PIM1 | 0.40554740 |
| 134 | BCKDK | 0.40412462 |
| 135 | CDK12 | 0.39465784 |
| 136 | PDK1 | 0.39094029 |
| 137 | EPHB1 | 0.38403392 |
| 138 | PLK4 | 0.37660500 |
| 139 | CSNK2A2 | 0.36633859 |
| 140 | TRIB3 | 0.35230369 |
| 141 | BRD4 | 0.34487601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.38458071 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.21789884 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.77030304 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.88569253 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 2.81037476 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.63524761 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.54320606 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.45636815 |
| 9 | Spliceosome_Homo sapiens_hsa03040 | 2.37797593 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.26825560 |
| 11 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.18358212 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.10657277 |
| 13 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.06980041 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 2.00180652 |
| 15 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.95605361 |
| 16 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.93425640 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.87213010 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.84350209 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.74697173 |
| 20 | Carbon metabolism_Homo sapiens_hsa01200 | 1.61780024 |
| 21 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.53477780 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.52927461 |
| 23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.49780541 |
| 24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.49063450 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.45448703 |
| 26 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.45215444 |
| 27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.42522841 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.37123205 |
| 29 | RNA transport_Homo sapiens_hsa03013 | 1.34879259 |
| 30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.34167359 |
| 31 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.29737199 |
| 32 | Leishmaniasis_Homo sapiens_hsa05140 | 1.28374492 |
| 33 | Cell cycle_Homo sapiens_hsa04110 | 1.26676128 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.23050649 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21583269 |
| 36 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.19986061 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.19624304 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.19251849 |
| 39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.19062302 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.17868260 |
| 41 | Malaria_Homo sapiens_hsa05144 | 1.17648119 |
| 42 | Measles_Homo sapiens_hsa05162 | 1.17378407 |
| 43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.17007524 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.13304637 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09236822 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.09199444 |
| 47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.08377719 |
| 48 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.07371022 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.05617520 |
| 50 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.04928766 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.04171243 |
| 52 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.03956945 |
| 53 | RNA degradation_Homo sapiens_hsa03018 | 1.03938033 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03330573 |
| 55 | * Purine metabolism_Homo sapiens_hsa00230 | 1.02890504 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02328646 |
| 57 | Basal transcription factors_Homo sapiens_hsa03022 | 0.99844062 |
| 58 | Histidine metabolism_Homo sapiens_hsa00340 | 0.98796052 |
| 59 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.96397156 |
| 60 | Huntingtons disease_Homo sapiens_hsa05016 | 0.95966549 |
| 61 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95695244 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 0.95604951 |
| 63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.94176355 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.93902771 |
| 65 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.93428052 |
| 66 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.93284196 |
| 67 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.92379108 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91799890 |
| 69 | Shigellosis_Homo sapiens_hsa05131 | 0.91741679 |
| 70 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.90937861 |
| 71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.86379181 |
| 72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.85630402 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84613923 |
| 74 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.84461095 |
| 75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84399241 |
| 76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82642665 |
| 77 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.81156388 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.80775037 |
| 79 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.80583880 |
| 80 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79297836 |
| 81 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.78615303 |
| 82 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.78537232 |
| 83 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.77232686 |
| 84 | Alzheimers disease_Homo sapiens_hsa05010 | 0.76231205 |
| 85 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74331277 |
| 86 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72838967 |
| 87 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70257166 |
| 88 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.69311176 |
| 89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.69032884 |
| 90 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67690516 |
| 91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67107951 |
| 92 | Influenza A_Homo sapiens_hsa05164 | 0.66147300 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 0.65381935 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.65364316 |
| 95 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.65068272 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65055489 |
| 97 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.64566329 |
| 98 | Sulfur relay system_Homo sapiens_hsa04122 | 0.63347176 |
| 99 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62834699 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62187223 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.60333209 |
| 102 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.60156500 |
| 103 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.59728775 |
| 104 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.59202108 |
| 105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57891616 |
| 106 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57756706 |
| 107 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.57108649 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56620929 |
| 109 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.55226196 |
| 110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54413027 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54251383 |
| 112 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.54227305 |
| 113 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.53056692 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52173147 |
| 115 | Hepatitis B_Homo sapiens_hsa05161 | 0.51392256 |
| 116 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.50569848 |
| 117 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50360447 |
| 118 | Tuberculosis_Homo sapiens_hsa05152 | 0.49313253 |
| 119 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49192524 |
| 120 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48798971 |
| 121 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.47401980 |
| 122 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47285139 |
| 123 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47284480 |
| 124 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46171832 |
| 125 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45769096 |
| 126 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45306373 |
| 127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45119012 |
| 128 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.44363878 |
| 129 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43095404 |
| 130 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.40941039 |
| 131 | Viral myocarditis_Homo sapiens_hsa05416 | 0.40170573 |
| 132 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40019382 |
| 133 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.39224918 |
| 134 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.38221148 |
| 135 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.36946938 |
| 136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36580198 |
| 137 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35807655 |

